Lotus Pharmaceuticals, Inc. Current with OTC MARKETS
Lotus Pharmaceuticals, Inc. (LTUS) announced its achievement of Current, Green-Light Status with OTC MARKETS, confirming compliance with all legal and financial requirements. President Georgene Rivers expressed enthusiasm about the company's future prospects, emphasizing that this status provides shareholders with essential information for investment decisions. However, the company cautioned that forward-looking statements could be affected by various risks and uncertainties that may influence actual results.
- Achievement of Current, Green-Light Status with OTC MARKETS enhances credibility.
- Compliance with legal and financial requirements indicates operational transparency.
- Management expresses optimism about future growth plans.
- Forward-looking statements are subject to significant business risks and uncertainties.
- The ability to increase revenue and profits is uncertain in the current economic climate.
NORTH PORT, Fla., March 16, 2021 /PRNewswire/ -- Lotus Pharmaceuticals, Inc (Pink Sheets: LTUS) President Georgene Rivers announced today that Lotus Pharmaceuticals, Inc. has become current with OTC MARKETS. The company has fulfilled all Legal and Financial Requirements needed to achieve a Current, Green-Light Status.
Rivers stated, "We have big plans for the coming year. I couldn't be more excited. Being current means our future and current shareholders have the information they need to make the most accurate investment decisions."
Safe Harbor Statement
This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: The Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes," "expects," "anticipates," "intends," "estimates," "plans," "projects," "should," or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.
View original content:http://www.prnewswire.com/news-releases/lotus-pharmaceuticals-inc-current-with-otc-markets-301249336.html
SOURCE Lotus Pharmaceuticals, Inc.
FAQ
What does it mean for LTUS to achieve Current, Green-Light Status?
Who is the President of Lotus Pharmaceuticals, Inc.?
What are the risks associated with Lotus Pharmaceuticals, Inc.'s forward-looking statements?
When did Lotus Pharmaceuticals announce its OTC MARKETS status?
